Mother-daughter team preaches the gospel of HIV prevention

December 24, 2013 by Serena Gordon, Healthday Reporter

(HealthDay)—Fortunata Kasege was just 22 years old and several months pregnant when she and her husband came to the United States from Tanzania in 1997. She was hoping to earn a college degree in journalism before returning home.

Because she'd been in the process of moving from Africa to the United States, Kasege had not yet had a prenatal checkup, so she went to a clinic soon after she arrived.

"I was very excited to be in the U.S., but after that long flight, I wanted to know that everything was OK," she said. "I went to the clinic with mixed emotions—excited about the baby, but worried, too," but she left the appointment feeling better about the baby and without worries.

That was the last time she'd have such a carefree feeling during her pregnancy.

Soon after her appointment, the clinic asked her to come back in: Her had come back positive for HIV.

"I was devastated because of the baby," Kasege said. "I don't remember hearing anything they said about saving the baby right away. It was a lot to take in," she added.

"I was crying and scared that I was going to die," she said. "I was feeling all kinds of emotions, and I thought my baby would die, too. I was screaming a lot, and finally someone told me, 'We promise we have medicine you can take and it can save the baby and you, too.' "

Kasege started treatment right away with zidovudine, which is more commonly called AZT. It's a drug that reduces the amount of virus in the body, known as the , and that helps reduce the chances of the baby getting the mother's infection.

"I had to take it every four hours, even in the middle of the night, so I set an alarm for the middle of the night," she said. "I had to make sure my baby would be OK. I had to do it precisely perfectly for my baby, and I didn't miss a dose. In 1997, the chance of transmission was said to be 12 percent, but my doctors said don't worry, we haven't seen anyone who's adhered to the medicine have a baby with HIV. And they were correct. My baby was healthy. And I was healthy. It was such a happy time that came from the worst feeling."

Kasege had a daughter, and she named her Florida. The baby's test came back negative for HIV, but to be safe, Kasege enrolled her in a study that tracked little Florida for two years to be sure she didn't develop HIV, the virus that causes AIDS. And, she didn't.

Florida is now 16 years old, and for years she's been helping her mother spread the word about preventing HIV infection. Kasege is an ambassador for the Elizabeth Glaser Pediatric AIDS Foundation.

"I want other women with HIV to know that you can have a good ending," Kasege said. "Your story doesn't have to end tragically. It's a bad feeling for a mom to even think about it. But, you can protect your baby. Be hopeful and stick to the treatment, and your baby will be fine."

Kasege's faithful adherence to her medication hasn't helped just her daughter but has helped her as well.

"My virus is undetectable, and it's been that way since three months after I started taking the medication," she said. "I worry about other things now, raising a teenager. I don't worry about HIV."

Explore further: Big strides in battle against pediatric AIDS

More information: This HealthDay story describes the gains in the fight against pediatrics AIDS cases in the United States.

Related Stories

Big strides in battle against pediatric AIDS

December 24, 2013
(HealthDay)—The effect that AIDS is having on American kids has improved greatly in recent years, thanks to effective drugs and prevention methods. The same cannot be said, however, for children worldwide.

Hungary: Baby delivered from brain-dead mother

November 13, 2013
A university hospital in Hungary says a premature but healthy baby was delivered after doctors kept the child's brain-dead mother on life support for three months.

Mississippi child points HIV researchers in new direction

April 25, 2013
(Medical Xpress)—Earlier this year, doctors at an infectious disease conference announced that a baby in rural Mississippi born with HIV had been "functionally cured" of the infection after receiving aggressive treatment ...

Drug combo much better than AZT alone at preventing mother-to-infant HIV transmission

June 20, 2012
Non-breastfed babies born to HIV-positive mothers who didn't receive antiretroviral therapy during pregnancy are routinely given zidovudine, commonly known as AZT, shortly after birth to prevent mother-to-child transmission ...

Hepatitis C screening for baby boomers

April 29, 2013
If you were born during 1945-1965, talk to your doctor about getting tested for hepatitis C. The word "hepatitis" means swelling of the liver. Hepatitis is most often caused by a virus. In the United States, the most common ...

Recommended for you

HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection

January 18, 2018
A first-of-its-kind study has found that the genetic diversity of human immunodeficiency virus type 1 (HIV-1) is higher in the vaginal tract than in the blood stream during early infection. This finding, published in PLOS ...

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

Usage remains low for pill that can prevent HIV infection

January 8, 2018
From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.